US FDA’s Marks Was Frustrated About Slow Completion Of 2021 Comirnaty Review

CBER Director Peter Marks told Janet Woodcock in an email that he thought reviewers were treating the BLA for the first fully approved COVID-19 vaccine as a conventional review or learning exercise.